Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
PetMed Express | PETS | Sep 27, 2024 | 3.68 | +1.10 |
Petroleo Brasileiro S.A.- Petrobras ADR | PBR | Sep 27, 2024 | 14.58 | +0.14 |
Petroleo Brasileiro S.A.- Petrobras ADR Pref | PBR-A | Sep 27, 2024 | 13.27 | +0.23 |
Petros Pharmaceuticals | PTPI | Sep 27, 2024 | 0.35 | +4.23 |
Pfizer | PFE | Sep 27, 2024 | 29.09 | +0.41 |
Pgim Global High Yield Fund | GHY | Sep 27, 2024 | 12.74 | +0.32 |
Pgim High Yield Bond Fund | ISD | Sep 27, 2024 | 14.00 | +0.29 |
PGIM Short Duration High Yield Opportunities Fund | SDHY | Sep 27, 2024 | 16.50 | -0.48 |
Pharmaceutical ETF Market Vectors | PPH | Sep 27, 2024 | 94.84 | -0.51 |
PharmaCyte Biotech | PMCB | Sep 27, 2024 | 1.84 | +2.22 |
Pharming Group ADR | PHAR | Sep 27, 2024 | 8.49 | +5.73 |
Pharvaris | PHVS | Sep 27, 2024 | 18.54 | -1.85 |
Phathom Pharmaceuticals | PHAT | Sep 27, 2024 | 17.52 | -1.68 |
PhenixFIN | PFX | Sep 27, 2024 | 47.00 | -0.09 |
Pheton | PTHL | Sep 27, 2024 | 4.83 | 0.00 |
Phibro Animal Health A | PAHC | Sep 27, 2024 | 22.07 | -0.14 |
Philip Morris | PM | Sep 27, 2024 | 120.62 | -0.19 |
Philippines Invstb Mkt Idx MSCI Ishares | EPHE | Sep 27, 2024 | 29.70 | -0.77 |
Phillips 66 | PSX | Sep 27, 2024 | 131.05 | +0.28 |
Phillips Edison & Company | PECO | Sep 27, 2024 | 37.26 | -0.29 |
PHINIA | PHIN | Sep 27, 2024 | 46.99 | +0.32 |
Phio Pharmaceuticals | PHIO | Sep 27, 2024 | 3.50 | -1.96 |
PHLX Semiconductor | SOX | Sep 27, 2024 | 5 217.23 | -1.76 |
PHLX Sox Semiconductor Sector Ishares | SOXX | Sep 27, 2024 | 232.68 | -1.59 |
Phoenix Biotech Acquisition Unit | PBAXU | Sep 27, 2024 | 10.37 | 0.00 |
Phoenix Motor | PEV | Sep 27, 2024 | 0.38 | -2.86 |
Phoenix New Media A ADR | FENG | Sep 27, 2024 | 3.01 | +4.51 |
Photronics | PLAB | Sep 27, 2024 | 24.80 | -0.20 |
Phreesia | PHR | Sep 27, 2024 | 22.72 | +2.34 |
Phunware | PHUN | Sep 27, 2024 | 3.46 | +5.49 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.